Cargando…
Immune checkpoint inhibitor lichenoid eruption due to pembrolizumab
Pembrolizumab is an immune checkpoint inhibitor used in many cancer types, including genitourinary cancers. Although immunotherapies have dramatically changed the landscape of cancer treatment by providing an alternative to traditional chemotherapy, they have been associated with significant immune-...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BMJ Publishing Group
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10314548/ https://www.ncbi.nlm.nih.gov/pubmed/37339826 http://dx.doi.org/10.1136/bcr-2023-254692 |